Breakthrough nerve-sensing technology has the potential to help treat a wide range of disorders
| | 
For many, pain can be a constant in life, which is why painkillers are such a huge market – despite typically being a temporary (and sometimes dangerous) "band-aid" solution.
Autonomix has a better idea: Target pain at its source in the nervous system.
Alongside pain management, their breakthrough nerve-sensing technology has the potential to help treat a wide range of disorders including high blood pressure and digestive issues. It's all with one tiny microchip that's intended to target nerve signals at an accuracy never seen before.
The team has 100+ patents issued and pending, and with an estimated total of $100B+ in markets to address, we believe it's a unique opportunity for investors.
Subscribe to updates and see how you can invest in Autonomix before their planned NASDAQ listing. (By clicking this link, you agree to receive future emails from Autonomix about company news and updates. You can opt out at any time. - Privacy Policy) | | Disclosure: This is a paid advertisement for Autonomix's Regulation A+ Offering. Please read the offering circular at invest.autonomix.com | |
No comments:
Post a Comment